AIOS vs. CDNA
AIOS (AIOS Tech, Inc.) and CDNA (CareDx, Inc) are both stocks. AIOS operates in Information Technology Services (Technology), while CDNA operates in Diagnostics & Research (Healthcare). Over the past 5 years, AIOS returned -64.97%/yr vs -23.19%/yr for CDNA. At a 0.13 correlation, their price movements are largely independent.
Performance
AIOS vs. CDNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AIOS achieves a -45.51% return, which is significantly lower than CDNA's 32.96% return.
AIOS
- 1D
- -13.31%
- 1M
- -27.40%
- YTD
- -45.51%
- 6M
- -59.23%
- 1Y
- -82.67%
- 3Y*
- -46.37%
- 5Y*
- -64.97%
- 10Y*
- —
CDNA
- 1D
- -4.32%
- 1M
- 15.81%
- YTD
- 32.96%
- 6M
- 25.12%
- 1Y
- 31.57%
- 3Y*
- 47.04%
- 5Y*
- -23.19%
- 10Y*
- 18.09%
AIOS vs. CDNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AIOS AIOS Tech, Inc. | -45.51% | -84.05% | 67.75% | -29.78% | -82.26% | -82.37% | 213.97% | 584.53% | -67.78% | -46.87% |
CDNA CareDx, Inc | 32.96% | -12.00% | 78.42% | 5.17% | -74.91% | -37.23% | 235.88% | -14.20% | 242.51% | 171.85% |
Correlation
The correlation between AIOS and CDNA is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Dec 27, 2016 | 0.13 |
Fundamentals
AIOS:
$2.70M
CDNA:
$1.33B
AIOS:
-$955.63
CDNA:
-$0.15
AIOS:
0.01
CDNA:
3.22
AIOS:
0.58
CDNA:
4.24
AIOS:
$344.69M
CDNA:
$412.82M
AIOS:
$33.75M
CDNA:
$198.97M
AIOS:
$9.69M
CDNA:
$4.15M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AIOS vs. CDNA — Risk / Return Rank
AIOS
CDNA
AIOS vs. CDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AIOS Tech, Inc. (AIOS) and CareDx, Inc (CDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AIOS | CDNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.88 | ||
| Sortino ratioReturn per unit of downside risk | -1.40 | ||
| Omega ratioGain probability vs. loss probability | 0.95 | 1.17 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | -0.91 | 0.72 | -1.63 |
| Martin ratioReturn relative to average drawdown | -1.39 | 1.50 | -2.89 |
Loading charts...
Drawdowns
AIOS vs. CDNA - Drawdown Comparison
The maximum AIOS drawdown since its inception was -99.84%, which is greater than CDNA's maximum drawdown of -94.87%. Use the drawdown chart below to compare losses from any high point for AIOS and CDNA.
Loading charts...
Drawdown Indicators
| AIOS | CDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.84% | -94.87% | -4.97% |
Max Drawdown (1Y)Largest decline over 1 year | -91.43% | -43.92% | -47.51% |
Max Drawdown (3Y)Largest decline over 3 years | -98.13% | -65.96% | -32.17% |
Max Drawdown (5Y)Largest decline over 5 years | -99.76% | -94.85% | -4.91% |
Max Drawdown (10Y)Largest decline over 10 years | — | -94.87% | — |
Current DrawdownCurrent decline from peak | -99.76% | -73.80% | -25.96% |
Average DrawdownAverage peak-to-trough decline | -74.24% | -53.75% | -20.49% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 59.53% | 21.10% | +38.43% |
Volatility
AIOS vs. CDNA - Volatility Comparison
AIOS Tech, Inc. (AIOS) has a higher volatility of 40.60% compared to CareDx, Inc (CDNA) at 16.23%. This indicates that AIOS's price experiences larger fluctuations and is considered to be riskier than CDNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AIOS | CDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 40.60% | 16.23% | +24.37% |
Volatility (6M)Calculated over the trailing 6-month period | 161.43% | 45.88% | +115.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 186.76% | 72.34% | +114.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 126.95% | 77.50% | +49.45% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 113.05% | 78.19% | +34.86% |
Dividends
AIOS vs. CDNA - Dividend Comparison
Neither AIOS nor CDNA has paid dividends to shareholders.
Financials
AIOS vs. CDNA - Financials Comparison
This section allows you to compare key financial metrics between AIOS Tech, Inc. and CareDx, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
AIOS and CDNA have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AIOS has higher volatility (40.60%) compared to CDNA (16.23%). In terms of maximum drawdown, AIOS dropped -99.84% vs CDNA's -94.87%.
CDNA currently has the higher Sharpe Ratio (0.44 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AIOS and CDNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer